Demonstration of three anomalous plasma proteins induced by a vitamin K antagonist by Reekers, P.P.M. et al.
 
 
 
Demonstration of three anomalous plasma proteins
induced by a vitamin K antagonist
Citation for published version (APA):
Reekers, P. P. M., Lindhout, M. J., Kop-Klaassen, B. H. M., & Hemker, H. C. (1973). Demonstration of
three anomalous plasma proteins induced by a vitamin K antagonist. Biochimica et Biophysica Acta (BBA)
- Protein Structure, 317(2), 559-562. https://doi.org/10.1016/0005-2795(73)90252-3
Document status and date:
Published: 01/01/1973
DOI:
10.1016/0005-2795(73)90252-3
Document Version:
Other version
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Jan. 2021
Biochimíca et Biophysica Acta, 3t7 (197 3) 559-562
@ Elsevier Scientific Publishing Company, Amsterdam - Printed in The Netherlands
BBA3T162
Demonstration of three anomalous plasma proteins induced by a vitamin K
Reprinted from
Biochimica et Biophysica Acta,3l7 (1973) 559-562
@ Elsevier Scientific Publishing Company, Amsterdam - Printed in The Netherlands
BBA Report
B B A  3 1 1 6 2
Demonstration of three anomalous plasma proteins induced by a vitamin K
antagonist
P.P.M. REEKERS, M.J. LINDHOUT, B.H.M. KOP-KLAASSEN and H.C. HEMKER
Laboratory for Cardiovascular and Blood Coagthtion Biochemistry, Leiden Uníversity Medical Centre,
Leíden lThe Netherlands)
(Received June 15th, 1973)
SUMMARY
With the aid of precipitating antibodies against the bovine coagulation factors II,
IX, and X three immunologica[y non-identical proteins can be demonstrated that are
induced by the administration of a vitamin K antagonist (phenprocoumon). Each of these
proteins is immunologically identical to one of three coagulation factors mentioned.
The proteins differ from normal coagulation factors (a) by a lack ofbiological
activity; (b) by a faster anodic migration rate in the presence of Ca2*.
The proteins appear in the plasma concomitantly with the decrease of the normal
factor.
In 1963 we reported experiments that led us to conclude that under conditions of
vitamin K deficiency (either absolute or induced by vitamin K antagonists), plasma contains
an anomalous prothrombin-like proteinr. At that time we postulated that this protein is a
pÍecursor of prothrombin that reaches the circulation because a postribosomal vitamin K-
dependent step in the synthesis of prothrombin is blocked.
I-ater, an abnormal prothrombin-like protein was demonstrated in the vitamin K-
deficient human2'3 as well as in the deficient cowa . This protein cannot be distinguished
from normal prothrombin in immunodiffusion tests, but in the presence of Ca2* it shows a
higher electrophoretic mobility than normal prothrombin.
It has been shown that after the start of oral anticoagulant treatment the abnormal
protein gradually increases concomitantly with the decrea,se of normal prothrombins.
Research at the cellular and subcellular levels (e.g. Suttie, ref. 6) made it probable
that vitamin K does act at a postribosomal step in protfuombin synthesis and that a protein
Abbreviation: PIVKA, protein induced by vitamin K absence.
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precuÍsor to prothrombin does exist. Since there are four vitamin K-dependent coagulation
factors (II, VII, IX, and X) the existence of four different precursors can be postulated. An
increased cellular concentration of these precursors could conceivably cause the occurrence
of proteins induced by vitamin K absence (PIVKA$ in the blood. Four precursors suggest
four PIVKAs, which can be designated PIVKA-II, PIVKA-VII, PIVKA-IX, and pIVKA-X.
Indirect evidence based on antibody neutralization and coagulation kinetics
suggests the existence in man of PIVI(A-IX and PIVKA-X in addition to PIVKA-II (refs 7-9).
The present report concerns the demonstration of the occurrence of PIVKA-IX
and PIVKA-X as well as PIVKA-II in the plasma of the anticoagulated cow.
We purified the bovine coagulation factors II, VII, IX, and X by A1(OH)3
adsorption, DEAE-cellulose chromatography, and preparative acrylamide gel
electrophoresis (for a full account of the methods see ref. 10), and immunized rabbits with
these preparations. We obtained highly specific antibodies against factors II, IX, and X, but
failed to obtain antibodies against factor VII.
Administration of phenprocoumon in a dose of 250 mg daily to a cow weighing
500 kg caused the expected decrease in the activity of factors II, VII, IX, and X. 24h after
the first dose, the plasma contained the following concentrations of coagulation factors:
prothrombin ,7 5%; factor Yrr,24%; factor IX, 50%; and factor X, 38%. After 100 h. the
plasma contained 23% of the original amount of prothrombin and less than 5% of that of
each of the other factors. All coagulation factor determinations were carried out in one-
stage assays as described in refs 1 | and 12.
calcium lactzte'(2 rnM) in 0.075 M barbital buffer at pH 3.6 as described by Ganrot and
Nileha3 . After the agarose slabs had been transferred to a square glass plate (20 mm x
l0 mm x 1 mm) and incorporated into an agaí gel containing the specific antibody, crossed
immunoelectrophoresís was carried out by applying 50 V for 4hin a direction
perpendicular to the first one. With normal plasma and each of the antibodies, a single peak
was obtained. Simultaneous incorporation of the three antibodies into one gel gave three
sepaÍate, non-identical peaks (Fig. 1, top), thus indicating the existence ofthree separate
antibody-antigen interactions. when plasma was adsorbed with A1(oH)3 -.gel (r.0% wlv)
to eliminate factors II, VII, IX, and X, no precipitation pattem was obtained. with plasma
\oi/ithdrawn 24 h after the first administration of phenprocoumon, a "camelback" pattern
was obtained. Each of the antibodies gave two partly separated peaks, one coÍresponding to
the normal factor, and the other to the faster-moving abnormal species. The continuity of
the pÍecipitation lines indicates immunological identity. Thus, the plasma contains one
abnormal molecular species corresponding to each of the three normal factors. This
indi'cates that PIVKA-IX and PIVKÁ-X exist as well as PIVKA-II, which can be elegantly
demonstrated by incorporating all three antibodies into the agarose gel used for the second
electrophoresis. when this is done, three groups of two peaks are observed. Mthin each
group there is complete identity; between the groups there is no identity (Fig. I , middle).
When prolonged anticoagulation leads to almost complete absence of factor IX and X
activity (< 57à, the crossed electrophoresis pattern (Fig. I , bottom) is consistent with
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Fig' l. Two-dimensional crossed electrophoresis of bovine plasmas against a mixture of antifactor II,
anti-factor IX, and anti-factor X present in the second (vertical) dimension. Top, normal plasma;Middle,
plasma after 24 h of anticoagulation; Bottom: plasma after 100 h of anticougulutiorr. The figures II, IX,
and X indicate the peaks obtained with the normal factors, the letters a, b, and c the corresponding fast-
moving proteins.
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expectation: only PIVKA-IX and PIVKA-X are observed and normal factors IX and X are
absent. This plasma contains a residual amount (23%) of normal factor II, which accounts
for the shoulder in the right side of the factor II precipitation line. The immunologicalnon-
identity of the PIVKAs is clearly demonstrated by Fig. 1, which shows that the
concentration of the PIVKAs increases concomitantly with the decrease of the normal
factors after the start of the administration of the phenprocoumon.
We are indebted to Dr M. Kunz of Hoffman-La Roche. Basel. Switzerland. for
providing the phenprocoumon.
REFERENCES
1 Hemker, H.C., Veltkamp, J.J., Hensen, A. and Loeliger, E.A. (1963) Nature 200,589-590
2 Josso, F. (1971) Blood 38,9-16
3 Ganrot, P.O. and Nilehn, J.E. (L968) Scand. L C:lín. Lab, Invest. 22, 23-28
4 Stenflo, J. (1970) Acta Chem. Scand.24,3762-3763
5 Brozovic, M. and Gurd, L. (I97 l) Lancet ll, 42'l -428
6 Suftie, J.W. (1970) Arch. Biochem. Biophys.l4l,57l-578
7 Hemker, H.C. (1971) Thromb. Díath. Haemorrh. Suppl. XLV, ttg-I24
8 Denson, K.W.E. (1971) Br. J. Haematol.20,643-648
9 Veltkamp, J.J., Muis, H., Muller, A.D. and Hemker, H.C. (1971) Thromb. Diath. Haemorrh.
25. 312-315
l0 Reekers, P.P.M. (1973) llaemostasis, in the press
1l Koller, F., Loeliger, E.A. and Duckert, F. (L95t)Acta Haematol.6, 1-18
12 Veltkamp, J.J., Loeliger, E.A. and Drion, E.F. (1968) Thromb. Diath. Haemorrh.19,403-422
